Patents by Inventor Mattias Algotsson

Mattias Algotsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220258130
    Abstract: The present invention relates to a novel chromatography media, more closely a novel IMAC (Immobilized Metal Affinity Chromatography) media. The novel chromatography media comprises a pentaligand and provides high dynamic binding capacity as well as high purity of the sample proteins purified on the media of the invention.
    Type: Application
    Filed: May 3, 2022
    Publication date: August 18, 2022
    Inventors: Ann Catharina Bergh, Mattias Algotsson, Tania Ahmad, Therese Graner
  • Patent number: 11014069
    Abstract: The present invention relates to a method to improve chromatography beads. More closely, the invention relates to a novel method for production of dextran-containing porous media and chromatography media produced with this method. In the method, the chromatography media is subjected to dextranase-treatment leading to improved pressure-flow properties of the media.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: May 25, 2021
    Assignee: Cytiva BioProcess R&D AB
    Inventors: Nils Norrman, Mattias Algotsson, Stefan D. Eriksson
  • Patent number: 10662261
    Abstract: The present invention relates to dimeric pentadentate chelators with exceptionally strong binding of metal ions, for detection, immobilization and purification of biomolecules. Dimeric chelators offer a cooperativity of binding of two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule, which gives advantageous properties regarding strength of binding compared to a corresponding monomer chelator. In addition, a dimer increases the selectivity (ease of separation) against non-tagged biomolecules with low metal-ion affinity.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: May 26, 2020
    Assignee: GE Healthcare BioProcess R&D AB
    Inventors: Mattias Algotsson, Lars C. Andersson, Eggert Brekkan, Lee Hedemyr, Jean-Luc Maloisel, Ronnie Palmgren
  • Publication number: 20200023338
    Abstract: The present invention relates to a novel chromatography media, more closely a novel IMAC (Immobilized Metal Affinity Chromatography) media. The novel chromatography media comprises a pentaligand and provides high dynamic binding capacity as well as high purity of the sample proteins purified on the media of the invention.
    Type: Application
    Filed: September 27, 2017
    Publication date: January 23, 2020
    Applicant: GE Healthcare BioProcess R&D AB
    Inventors: Ann Catharina Bergh, Tania Ahmad, Mattias Algotsson, Therese Graner
  • Patent number: 10371608
    Abstract: The invention discloses a cellulose or glass fiber paper for preservation of biological samples, which comprises 4-30 wt % of a hydrophilic branched carbohydrate polymer. It also discloses a method for preservation of biological samples by applying and drying them on the paper.
    Type: Grant
    Filed: October 29, 2012
    Date of Patent: August 6, 2019
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Mattias Algotsson, Miles W. Burrows, Jimmy Hedin Dahlstrom, Ylva Laurin, Ronnie Palmgren, Jinyu Zou
  • Publication number: 20180304231
    Abstract: The present invention relates to a method to improve chromatography beads. More closely, the invention relates to a novel method for production of dextran-containing porous media and chromatography media produced with this method. In the method, the chromatography media is subjected to dextranase-treatment leading to improved pressure-flow properties of the media.
    Type: Application
    Filed: October 28, 2016
    Publication date: October 25, 2018
    Applicant: GE Healthcare Bio-Sciences AB
    Inventors: Nils Norrman, Mattias Algotsson, Stefan D. Eriksson
  • Publication number: 20180223003
    Abstract: The present invention relates to dimeric pentadentate chelators with exceptionally strong binding of metal ions, for detection, immobilization and purification of biomolecules. Dimeric chelators offer a cooperativity of binding of two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule, which gives advantageous properties regarding strength of binding compared to a corresponding monomer chelator. In addition, a dimer increases the selectivity (ease of separation) against non-tagged biomolecules with low metal-ion affinity.
    Type: Application
    Filed: March 27, 2018
    Publication date: August 9, 2018
    Inventors: Mattias Algotsson, Lars C. Andersson, Eggert Brekkan, Lee Hedemyr, Jean-Luc Maloisel, Ronnie Palmgren
  • Patent number: 9989446
    Abstract: The invention discloses a sample preservation method which comprises the following steps: a) providing a paper substrate comprising ligands, where the ligands comprise charged groups, b) applying a sample comprising at least one analyte and at least one contaminant on the paper substrate, c) drying the sample on the paper substrate and, d) extracting at least part of the paper substrate to provide a solution of the analyte.
    Type: Grant
    Filed: February 27, 2012
    Date of Patent: June 5, 2018
    Assignee: GE HEALTHCARE UK LIMITED
    Inventors: Philip Robert Mallender, Douglas Mark Green, Sarah Janet Clegg, Barry Edmund Johnson, Jimmy Hedin Dahlstrom, Mattias Algotsson, Ronnie Palmgren
  • Patent number: 9944722
    Abstract: The present invention relates to dimeric pentadentate chelators with exceptionally strong binding of metal ions, for detection, immobilization and purification of biomolecules. Dimeric chelators offer a cooperativity of binding of two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule, which gives advantageous properties regarding strength of binding compared to a corresponding monomer chelator. In addition, a dimer increases the selectivity (ease of separation) against non-tagged biomolecules with low metal-ion affinity.
    Type: Grant
    Filed: May 30, 2011
    Date of Patent: April 17, 2018
    Assignee: GE Healthcare Bioprocess R&D AB
    Inventors: Mattias Algotsson, Lars C. Andersson, Eggert Brekkan, Lee Hedemyr, Jean-Luc Maloisel, Ronnie Palmgren
  • Publication number: 20140302521
    Abstract: The invention discloses a cellulose or glass fibre paper for preservation of biological samples, which comprises 4-30 wt % of a hydrophilic branched carbohydrate polymer. It also discloses a method for preservation of biological samples by applying and drying them on the paper.
    Type: Application
    Filed: October 29, 2012
    Publication date: October 9, 2014
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Mattias Algotsson, Miles W. Burrows, Jimmy Hedin Dahlstrom, Ylva Laurin, Ronnie Palmgren, Jinyu Zou
  • Publication number: 20130330751
    Abstract: The invention discloses a sample preservation method which comprises the following steps: a) providing a paper substrate comprising ligands, where the ligands comprise charged groups, b) applying a sample comprising at least one analyte and at least one contaminant on the paper substrate, c) drying the sample on the paper substrate and, d) extracting at least part of the paper substrate to provide a solution of the analyte.
    Type: Application
    Filed: February 27, 2012
    Publication date: December 12, 2013
    Applicant: GE HEALTHCARE UK LIMITED
    Inventors: Philip Robert Mallender, Douglas Mark Green, Sarah Janet Clegg, Barry Edmund Johnson, Jimmy Hedin Dahlstrom, Mattias Algotsson, Ronnie Palmgren
  • Publication number: 20130072638
    Abstract: The present invention relates to dimeric pentadentate chelators with exceptionally strong binding of metal ions, for detection, immobilization and purification of biomolecules. Dimeric chelators offer a cooperativity of binding of two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule, which gives advantageous properties regarding strength of binding compared to a corresponding monomer chelator. In addition, a dimer increases the selectivity (ease of separation) against non-tagged biomolecules with low metal-ion affinity.
    Type: Application
    Filed: May 30, 2011
    Publication date: March 21, 2013
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Mattias Algotsson, Lars C. Andersson, Eggert Brekkan, Lee Hedemyr, Jean-Luc Maloisel, Ronnie Palmgren
  • Publication number: 20110039336
    Abstract: The present invention relates to a product for cell culture. In particular, the invention relates to a cell growth surface having a coating comprising an animal protein free coating. The coating is derived from an enzymatic hydrolysate of a plant protein, preferably soy peptone. The cell culture product is preferably a microcarrier intended for culture of any anchorage-dependent cells.
    Type: Application
    Filed: April 24, 2009
    Publication date: February 17, 2011
    Inventors: Mattias Algotsson, Asa Bjurling
  • Publication number: 20100136647
    Abstract: The present invention relates to the field of adherent cell culture. More closely, the invention relates to a method for production of a cell attachment and culture surface, such as a microcarrier, comprising a guanidino-containing ligand, wherein the ligand is coupled via reaction involving a primary amine to the surface which is activated by activation groups such that the final molar ratio of grafted ligand and ungrafted activation groups is above 1.5. Preferably, the ligand density is above 0.5 mmol/g cell culture surface and the remaining activation groups after coupling is less than 0.6 mmol/g cell culture surface. The cell culture surface may be used for various purposes, primarily cell cultivation and virus production.
    Type: Application
    Filed: November 23, 2009
    Publication date: June 3, 2010
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Mattias Algotsson, Hans Berg, Asa Bjurling, Christian Kaisermayer, Bjorn Noren, Nicholas Thevenin, James Van Alstine
  • Publication number: 20080199959
    Abstract: The present invention relates to a method for cell culture, more precisely small scale cell culture. In the present invention a screening tool is used which comprises particulate matter or microcarriers, such as beads, attached to a solid support, such as a microtiter plate, for the cultivation of cells on said microcarriers. The microcarriers are preferably cultivation beads, such as CYTODEX™. According to the invention, this small scale format for cell cultivation may be used for any testing involving cells, for example testing of optimal growth conditions for a specific type of cell, such as stem cells. Another use is cell expansion.
    Type: Application
    Filed: June 19, 2006
    Publication date: August 21, 2008
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Mattias Algotsson, Gunnar Glad, Nicolas Thevenin
  • Patent number: 7294743
    Abstract: The present invention relates to a method for synthesis of an acrylamide derivative, starting with dissolving a salt of a nucleophilic amine in water to form an aqueous solution and desalting said solution with a base, comprising the following steps: a) addition of dissolved activated acrylic acid derivative to said solution; b) acidification of aqueous phase; and c) extraction of said aqueous phase.
    Type: Grant
    Filed: October 18, 2004
    Date of Patent: November 13, 2007
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Mattias Algotsson, Philippe Busson, Nicolas Thevenin
  • Publication number: 20070106090
    Abstract: The present invention relates to a method for synthesis of an acrylamide derivative, starting with dissolving a salt of a nucleophilic amine in water to form an aqueous solution and desalting said solution with a base, comprising the following steps: a) addition of dissolved activated acrylic acid derivative to said solution; b) acidification of aqueous phase; and c) extraction of said aqueous phase. In a preferred embodiment the acryl amide derivative is an immobiline, preferably acrylamido agmatine. The preferred use of the immobilines is for production of 2D gels.
    Type: Application
    Filed: October 18, 2004
    Publication date: May 10, 2007
    Inventors: Mattias Algotsson, Philippe Busson, Nicolas Thevenin
  • Patent number: 7060776
    Abstract: The invention relates to an acrylic monomer defined by formula (I): wherein R1, R2 and R3 are H or CH3; R4 and R5 are H or OH; R6 and R7 are H or OH; R8 is H or CH3; m is 2–4; and n and p are 0 or 1. The invention also relates to a polymer comprised of repeated such monomer units as well as a separation matrix prepared thereof.
    Type: Grant
    Filed: December 17, 2002
    Date of Patent: June 13, 2006
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Mattias Algotsson, Bengt Bjellqvist, Ronnie Palmgren
  • Publication number: 20050113539
    Abstract: The invention relates to an acrylic monomer defined by formula (1): wherein R1, R2 and R3 are H or CH3; R4 and R5 are H or OH; R6 and R7 are H or OH; R8 is H or CH3; m is 2-4; and n and p are 0 or 1. The invention also relates to a polymer comprised of repeated such monomer units as well as a separation matrix prepared thereof.
    Type: Application
    Filed: December 17, 2002
    Publication date: May 26, 2005
    Inventors: Mattias Algotsson, Bengt Bjellqvist, Ronnie Palmgren